- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Environmentally-Friendly
Global Pharmaceuticals & Biotech Environmentally-Friendly
UPDATED Dec 17, 2023
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
3,174 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 858Extrawell Pharmaceutical Holdings | HK$0.035 | 6.1% | -57.8% | HK$81.3m | HK$218.63 | PS1.2x | E27.0% | n/a | ||
| 300896Imeik Technology DevelopmentLtd | CN¥279.52 | -0.2% | -46.1% | CN¥60.1b | CN¥540.40 | PE35.6x | E28.5% | 1.3% | ||
| 688131Shanghai Haoyuan Chemexpress | CN¥51.05 | -3.3% | -29.4% | CN¥7.8b | CN¥68.00 | PE49.9x | E46.4% | 0.5% | ||
| RICHTERRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt | Ft8,890.00 | 1.5% | -1.8% | Ft1.6t | Ft10,631.11 | PE20.1x | E33.5% | 4.4% | ||
| CYCCCyclacel Pharmaceuticals | US$3.58 | -12.0% | -68.8% | US$3.0m | US$13.67 | PS7.8x | E33.2% | n/a | ||
| BSEMBioStem Technologies | US$5.30 | 26.2% | 51.4% | US$85.7m | US$9.25 | PS14.2x | E95.8% | n/a | ||
| NICANanologica | kr9.84 | -6.3% | -17.3% | kr355.7m | kr14.75 | PS59.9x | E90.2% | n/a | ||
| ETONEton Pharmaceuticals | US$4.45 | 13.2% | 45.9% | US$114.2m | US$10.00 | PE51.2x | E21.0% | n/a | ||
| MARIMarinomed Biotech | €32.50 | -2.1% | -43.6% | €49.4m | €66.53 | PS4.4x | E74.8% | n/a | ||
| AELISAelis Farma | €13.35 | 0% | 18.6% | €175.3m | €21.50 | PS17.9x | E29.2% | n/a | ||
| CRMDCorMedix | US$3.31 | 0.6% | -12.7% | US$181.4m | US$14.25 | PS6105.8x | E62.3% | n/a | ||
| ISABInhalation Sciences Sweden | kr4.59 | 8.5% | -2.1% | kr69.6m | kr17.00 | PS4.2x | E101.8% | n/a | ||
| MDWDMediWound | US$10.53 | 1.9% | 12.3% | US$97.1m | US$28.00 | PS3.9x | E64.1% | n/a | ||
| IMMImmutep | AU$0.35 | 16.4% | 16.4% | AU$380.4m | AU$1.26 | PS120.4x | E57.0% | n/a | ||
| PIQProteomics International Laboratories | AU$0.83 | -3.5% | -4.0% | AU$99.7m | AU$2.42 | PS31.9x | E59.9% | n/a | ||
| BFRIBiofrontera | US$2.96 | -14.0% | -81.5% | US$4.5m | US$20.00 | PB4.3x | E71.5% | n/a | ||
| HYLHyloris Pharmaceuticals | €11.70 | -2.5% | -7.9% | €327.6m | €19.90 | PS106.4x | E116.2% | n/a | ||
| PGENPrecigen | US$1.22 | 5.2% | -18.1% | US$303.7m | US$9.46 | PS44.9x | E50.4% | n/a | ||
| 4880CellSource | JP¥1,361.00 | -6.2% | -70.6% | JP¥32.9b | JP¥2,300.00 | PE29.1x | E20.9% | n/a | ||
| TBPHTheravance Biopharma | US$10.99 | 1.9% | 4.4% | US$547.3m | US$14.50 | PS10x | E61.5% | n/a | ||
| 4579RaQualia Pharma | JP¥623.00 | -11.8% | -51.9% | JP¥14.1b | JP¥1,800.00 | PE96.9x | E128.3% | n/a | ||
| 4597Solasia Pharma K.K | JP¥57.00 | -6.6% | 18.8% | JP¥9.3b | JP¥70.00 | PS7.9x | E72.5% | n/a | ||
| 688566Jiangsu Jibeier Pharmaceutical | CN¥29.59 | 6.4% | 22.6% | CN¥5.6b | n/a | PE24.3x | E35.5% | 0% | ||
| 688687Beijing Kawin Technology Share-Holding | CN¥32.96 | -4.8% | 68.9% | CN¥5.6b | n/a | PE52.4x | E30.8% | 0.6% |